Search

RU-2026110947-A - COMPONENTS BASED ON MICROORGANISMS OF THE GENUS BACILLUS FOR THE SUPPRESSION OR SLOWING OF THE GROWTH OF ENTEROCOCCUS SPP. IN ANIMALS

RU2026110947ARU 2026110947 ARU2026110947 ARU 2026110947ARU-2026110947-A

Inventors

  • БЕРНАРДО, Марион
  • ГИББЗ, Керсти

Assignees

  • ИНТЕРНЭШНЛ Эн энд Эйч ДЕНМАРК АпС

Dates

Publication Date
20260507
Application Date
20240910
Priority Date
20230911

Claims (18)

  1. 1. A method for suppressing or slowing down, in whole or in part, the growth of pathogenic Enteroccocus spp. in an animal, comprising administering to the animal an effective amount of at least one component based on microorganisms of the genus Bacillus , selected from the group consisting of a direct-feeding microbial preparation based on microorganisms of the genus Bacillus , containing one or more bacterial strains of the genus Bacillus , a supernatant obtained from a culture of microorganisms of the genus Bacillus , and a combination thereof, wherein said pathogenic Enteroccocus spp. is selected from the group consisting of E. avium, E. casseliflavus, E. durans, E. faecalis, E. faecium, E. hirae and E. mundtii.
  2. 2. The method according to claim 1, wherein the direct feeding microbial preparation based on microorganisms of the genus Bacillus is selected from the group consisting of Bacillus velezensis , Bacillus amyloliquefaciens , Bacillus licheniformis , Bacillus pumilis and Baccillus subtilis .
  3. 3. The method according to claim 1 or 2, wherein the direct feeding microbial preparation based on microorganisms of the genus Bacillus is selected from the group consisting of one or more of the following strains: Bacillus strain 2084 under accession number NRR1 B-50013, Bacillus strain LSSAO1 under accession number NRRL B-50104 and Bacillus strain 15A-P4 under accession number PTA-6507 in ATCC.
  4. 4. The method according to claim 1 or 2, wherein the animal is a monogastric animal.
  5. 5. The method according to claim 3, wherein the animal is a monogastric animal.
  6. 6. The method according to claim 1 or 2, wherein the animal is an animal with a multi-chambered stomach.
  7. 7. The method according to claim 3, wherein the animal is an animal with a multi-chambered stomach.
  8. 8. The method according to claim 1 or 2, wherein the monogastric animal is a poultry.
  9. 9. The method according to claim 3, wherein the monogastric animal is a poultry.
  10. 10. The method according to claim 1 or 2, wherein at least one component based on microorganisms of the genus Bacillus is administered to the animal directly with animal feed, and is either contained in the feed, or is located on top of the feed, or is contained in a liquid.
  11. 11. The method according to claim 10, wherein at least one component based on microorganisms of the genus Bacillus is administered to the animal directly through the drinking system.
  12. 12. The method according to claim 3, wherein at least one component based on microorganisms of the genus Bacillus is administered to the animal directly with animal feed, and is either contained in the feed, or is located on top of the feed, or is contained in a liquid.
  13. 13. The method according to claim 12, wherein at least one component based on microorganisms of the genus Bacillus is administered to the animal directly through the drinking system.
  14. 14. The method according to claim 10, wherein at least one component based on microorganisms of the genus Bacillus is administered to the animal in a form selected from the group consisting of a feed product, a feed additive composition, a premix or a liquid.
  15. 15. The method according to claim 12, wherein the component based on microorganisms of the genus Bacillus is administered to the animal in a form selected from the group consisting of a feed product, a feed additive composition, a premix or a liquid.
  16. 16. The method according to any one of claims 1-15, further comprising administering to the animal one or more enzymes selected from the group consisting of phytase, protease, amylase, xylanase, lipase or glucoamylase.
  17. 17. The method according to claim 16, wherein the enzymes include xylanase, amylase and protease.
  18. 18. The method of any one of claims 1-17, wherein the method provides for a slowdown or suppression of the growth of pathogenic Enteroccocus spp. in an animal by about 5-100% (such as any value of about 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 100%, including any intermediate percentages between these values) compared to animals that have not been administered an effective amount of at least one component based on microorganisms of the genus Bacillus .